Anupreet Tumber

Anupreet Tumber

Auto-generated profile, based on publicly available information

Anupreet Tumber

Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
ATAlaa Tayyib
Alaa Tayyib
DPDeepika C Parameswarappa
Deepika C Parameswarappa
PKPeter J. Kertes
Peter J. Kertes
RMRajeev Muni
Rajeev Muni
ATAnupreet Tumber
Anupreet Tumber
EHElise Héon
Elise Héon
Assess safety and effectiveness of subretinal gene replacement therapy at 18 months post treatment. Retrospective, longitudinal study conducted at the Hospital for Sick Children in Toronto, Canada. Patients with bi-allelic RPE65 variants, early onset retinal degeneration, and residual viable retina who underwent voretigene neparvovec r-zyl gene replacement therapy. Data collected included demographic information, molecular genetic results, and comprehensive ocular assessment results from preoperataive and postoperative visits up to 18 months. To assess the treatment's efficacy, postoperative best corrected visual acuity, full-field stimulus test (FST), visual field (VF) area, optical coherence tomography, and global satisfaction were compared to preoperative findings. The procedures were safe with no complications. There was no significant improvement in visual acuity. Three eyes showed a slight reduction in VF area. All showed a reduction in ellipsoid zone thickness and area, but the outer nuclear layer thickness and area were stable. All had a significant improvement in retinal sensitivity, as per FST, allowing better navigation in a dim environment. All 3 patients reported being "very satisfied". Following a safe gene replacement therapy, the 3 first Canadian cases had an improvement in retinal sensitivity as per FST, and our patients described their experience as positively life changing.

28 June 2025 in Documenta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
GVGiulia Steuernagel Del Valle
Giulia Steuernagel Del Valle
HAHaipha Ali
Haipha Ali
JGJohn R. Grigg
John R. Grigg
RHRuth Hamilton
Ruth Hamilton
Michael B. HoffmannMichael B. Hoffmann
Michael B. Hoffmann
GWGerard C. de Wit
Gerard C. de Wit

27 February 2026 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
Kirk AJ StephensonKirk AJ Stephenson
Kirk AJ Stephenson
AAAbrar K. Alsalamah
Abrar K. Alsalamah
ATAnupreet Tumber
Anupreet Tumber
GMGareth D. Mercer
Gareth D. Mercer
BBBrian G Ballios
Brian G Ballios
EHElise Héon
Elise Héon